Clinical Pediatric Dermatology Open Access

  • ISSN: 2472-0143
  • Journal h-index: 3
  • Journal CiteScore: 0.24
  • Journal Impact Factor: 0.11
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days

Commentary - (2021) Volume 7, Issue 4

infantile Hemangioma and its Diagnosis

Richard Jones*

Department of Pediatric Dermatology, University of Ilorin, Ilorin, Nigeria

*Corresponding Author:
Richard Jones
Department of Pediatric Dermatology,
University of Ilorin,
Ilorin,
Nigeria
E-mail:
jones.richard@unilon.edu.ng

Received Date: November 04, 2021; Accepted Date: November 18, 2021; Published Date: November 25, 2021

Citation: Jones R (2021) Infantile Hemangioma and its Diagnosis. Clin Pediatr Dermatol Vol 7 No.4:001.

Visit for more related articles at Clinical Pediatric Dermatology

Description

Infantile hemangioma is a red birthmark that shows up at the beginning of the first or second week of birth. It may be there when a baby is born or form within a few weeks or months of birth. The majority of infantile haemangioma occurs shortly after delivery or at the time of birth. At the birth time or within a few weeks after the birth, most infantile hemangiomas leave a mark or colored patch on the skin. The most frequent tumor that affects babies is infantile haemangioma. Infantile haemangioma is more common in girls than boys, and Caucasian children are more likely to have them.

Haemangioma in children is segregated as superficial, deep, or mixed. Infantile hemangioma disease affects the skin and other soft tissues. A superficial hemangioma is a lesion on the skin's surface. A deep hemangioma is a type of hemangioma that develops beneath the skin. When a lesion has both surface and deep components, or when the lesion has both superficial and deep components, it is referred to as a combination or mixed hemangioma. Superficial lesions or mark shows on the skin as bright red and elevated. They might also have a strawberry-shaped textured region. Infantile hemangiomas are more common in babies who are born prematurely or with low birth weight. Infantile hemangiomas appear within the first few days to weeks of a baby's life. Congenital hemangiomas are hemangiomas that are apparent at birth. They develop in different ways and are treated in different ways.

Haemangioma in children is far more common than hemangiomas in adults. The following are the two most common kinds of infantile hemangiomas: Hemangiomas that grow on the skin's surface are called superficial hemangiomas or cutaneous ("in-the-skin") hemangiomas. Because of their bumpy red look, they have been termed strawberry hemangiomas or strawberry markings. Deep hemangiomas are a type of hemangioma which grows beneath the skin and causes it to swell, frequently with a blue or purple tint. Subcutaneous ("under the skin") hemangiomas are a type of deep hemangioma. Most infantile hemangiomas grow larger for a few months before slowly shrinking. During the first three months, they grow fast. Shrinking can begin as early as the second year and last until the child reaches the age of seven. Hemangiomas in children frequently diminish to the point where they are no longer visible. Hemangiomas are called tumors because they grow and change, but they are not cancerous. During the first year of a child's life, the red mark transforms into a spongy, rubbery-looking lump that protrudes from the skin. The hemangioma then enters a resting phase, after which it gradually fades away. Treatment is done based on several factors. The three most popular treatments are drug therapy, laser therapy, and surgical removal.

In the proliferative section of complicated hemangiomas, medicines can be effective. Cryosurgery has not often been used inside the remedy of facial and cervical hemangiomas due to its unsure efficacy and the opportunity of scarring or pigmentation. If a neonate is suffering from more than one hemangiomas then Pharmacotherapy proves to be useful therapy, proliferative hemangioma, and hemangiomas which might be affecting critical organs or lifestyles threatening. Several capsules had been used which include propranolol, corticosteroids, alphainterferon, anti-most cancers capsules like cyclophosphamide, vincristine, pingyangmycin, imiquimod.